Sales & Earnings In Brief

McNeil Q2 sales: Second quarter U.S. sales growth of 19% in OTC unit fueled by increased promotional activities for adult Tylenol, pediatric Motrin brands, J&J says during July 16 analysts call. McNeil domestic sales reached $359 mil. in the period, offsetting a 7% decline in international sales to $65 mil. Worldwide revenues for women's health products up 5% to $321 mil. in the quarter, contributing to 7.8% global sales advance to $1.65 bil. for the overall J&J Consumer segment, which includes skin care and baby care products in addition to McNeil and women's health. Also contributing to the gain wereNeutrogena, Clean & Clear skin care products, Viactiv chewable calcium supplements, J&J notes...

More from Archive

More from Pink Sheet